NCT01143792

Brief Summary

Youth who leave home for the streets are at significantly more risk for a multitude of problems, yet little research is available to guide treatment intervention efforts with this population. Studies document high rates of substance use, HIV risk, mental health problems, teenage pregnancy and criminality. Research to date examining homeless, street living youth has been primarily descriptive; less effort has been directed towards developing and evaluating treatment interventions for this group. The majority of homeless youth do not receive substance abuse treatment, with one study reporting that only 15% of street living youth report ever receiving mental health services. The effectiveness of the Community Reinforcement Approach (CRA) with street living youth was studied in our recently completed Stage 1 trial. The proposed study is a Stage II clinical trial examining outcome of CRA individual therapy as compared to two interventions commonly employed, yet little researched, with this group. All clients will be randomized to one of three theoretically distinct interventions: (1) CRA therapy, (2) Motivational Enhancement Therapy (MET), or (3) Case Management (CM). The relative effectiveness of these interventions will be evaluated at 3, 6, and 12 months post-baseline. The Social Ecology Theory of Development (Bronfenbrenner, 1979) guides our change hypotheses and intervention. Proposed change mechanisms (mediators) for each intervention will be evaluated. Differential treatment response as a function of ethnicity, gender, age, sexual orientation and abuse (moderators) will be investigated to better understand the interventions. The study will also examine how, if at all, treatment engagement, retention and expectations impact youth response to the three treatments. Information gained through this project may help address the gap in our understanding of how best to effectively intervene with a group at high risk for continuing health and psychological problems.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Sep 2006

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2006

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 14, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
11 months until next milestone

Results Posted

Study results publicly available

April 16, 2013

Completed
Last Updated

April 16, 2013

Status Verified

April 1, 2013

Enrollment Period

4.3 years

First QC Date

June 11, 2010

Results QC Date

December 13, 2012

Last Update Submit

April 12, 2013

Conditions

Keywords

Substance abuseHomelessnessHIV risk behavior

Outcome Measures

Primary Outcomes (3)

  • Substance Use

    Percentage of substance use days in prior three months.

    Three months

  • Substance Use

    Percentage of substance use days in prior three months

    Six months

  • Substance Use

    Percentage of substance use days in prior six months

    Twelve months

Secondary Outcomes (6)

  • HIV Risk

    Three months

  • HIV Risk

    Six months

  • HIV Risk

    Twelve months

  • Depressive Symptoms

    Three months

  • Depressive Symptoms

    Six months

  • +1 more secondary outcomes

Study Arms (3)

CRA + HIV prevention

EXPERIMENTAL
Behavioral: Community Reinforcement Approach (CRA) + HIV prevention

Case Management + HIV prevention

ACTIVE COMPARATOR
Behavioral: Case Management + HIV Prevention

MET + HIV prevention

ACTIVE COMPARATOR
Behavioral: Motivational Enhancement Therapy (MET) + HIV prevention

Interventions

12 sessions of the CRA and 2 sessions of HIV prevention.

CRA + HIV prevention

12 sessions of case management and 2 sessions of HIV prevention.

Case Management + HIV prevention

2 sessions of MET and 2 sessions of HIV prevention.

MET + HIV prevention

Eligibility Criteria

Age14 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Youth are between the ages of 14-20.
  • Youth have plans to remain in the Columbus areas for at least 12 months.
  • Youth meets abuse or dependence DSM-IV criteria for Psychoactive Substance Use or Alcohol disorder, as assessed by the computerized diagnostic interview schedule for children (CDISC, Shaffer, 1992).
  • Youth agrees to participate in the assessment and treatment intervention.
  • Youth meets criteria for homelessness as defined by DHHS.

You may not qualify if:

  • \. Evidence of unremitted psychosis or other condition which would impair their ability to understand and participate in the intervention or consent for research participation (as determined by CDISC).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Case ManagementMotivational Interviewing

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Patient Care PlanningComprehensive Health CarePatient Care ManagementHealth Services AdministrationDirective CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Natasha Slesnick
Organization
The Ohio State University

Study Officials

  • Natasha Slesnick, Ph.D.

    Ohio State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D.

Study Record Dates

First Submitted

June 11, 2010

First Posted

June 14, 2010

Study Start

September 1, 2006

Primary Completion

December 1, 2010

Study Completion

June 1, 2012

Last Updated

April 16, 2013

Results First Posted

April 16, 2013

Record last verified: 2013-04

Locations